Nanomedicine – a review
DOI:
https://doi.org/10.15584/ejcem.2022.1.14Keywords:
nanomedicine, nanoscale, nanostructureAbstract
Introduction and aim. Nanomedicine is a discipline of technology and science, the potential of which has recently fascinated scientists in the fields of physics, biotechnology, chemistry and medicine. This department deals with everything on the nano scale, i.e. on the level of individual atoms and molecules. This work presents the nano scale, i.e. on the level of individual atoms and molecules. Nanotechnology is currently one of the most popular and dynamically developing fields, not only in electronics, but above all in pharmacy and medicine.
Material and methods. In this article a narrative review regarding nanomedicine.
Analysis of the literature. The desire to summarize information about nanomedicine application of singlet oxygen is presented. Nanotechnology is a discipline of technology and science, the potential of which has recently fascinated scientists in the fields of physics, biotechnology, chemistry and medicine.
Conclusion. The use of nanostructures is currently very efficient. The areas in which the potential of nanoparticles is constantly researched and confirmed by numerous articles are: radio- and chemotherapy, cancer diagnostics and imaging medicine (MRI and fluorescence imaging).
Downloads
References
Jeevanandam J, Barhoum A, Chan YS, Dufresne A, Danquah MK. Review on nanoparticles and nanostructured materials: history, sources, toxicity and regulations. Beilstein J Nanotechnol. 2018;9:1050-1074.
Bayda S, Adeel M, Tuccinardi T, Cordani M, Rizzolio F. The History of nanoscience and nanotechnology: from chemical-physical applications to nanomedicine. Molecules, 2019;25(1):112.
Mehnath S, Kumar Das A, Kumar Verma S, Jeyaraj M. Chapter 9-Biosynthesized/green-synthesized nanomaterials as potential vehicles for delivery of antibiotics/drugs. Compr Anal Chem. 2021;94:363-432.
Griffin S, Masood MI, Nasim MJ, et al. Natural nanoparticles: a particular matter inspired. Antioxidant (Basel). 2017;7(1):3.
Boverhof DR, Bramante CM, Butala JH, et al. Comparative assessment of nanomaterial definitions and safety evaluation considerations. Regul Toxicol Pharmacol. 2015;73(1):137-150.
Kumar P, Saini M, Dehiya BS, et al Comprehensive survey on nanobiomaterials for bone tissue engineering applications. Nanomaterials (Basel). 2020;10(10):2019.
Mabrouk M, Das DB, Salem ZA, Beherei HH. Nanomaterials for biomedical applications: production, characterisations, recent trends and difficulties. Molecules. 2021;26(4):1077.
Salah N, Habib SS, Khan ZH, et al. High-energy ball milling technique for ZnO nanoparticles as antibacterial material. Int J Nanomedicine. 2011;6:863-869.
Thiruvengadam M, Rajakumar G, Chung IM. Nanotechnology: current uses and future applications in the food industry. 3 Biotech. 2018;8(1):74.
Sanna V, Pala N, Sechi M. Targeted therapy using nanotechnology: focus on cancer. Int J Nanomedicine. 2014;9:467-483.
Zielińska A, Carreiró F, Oliveira AM, et al. Polymeric nanoparticles: production, characterization, toxicology and ecotoxicology. Molecules, 2020;25(16):3731.
Miele E, Spinelli GP, Miele E, Tomao F, Tomao S. Albumin-bound formulation of paclitaxel (Abraxane ABI-007) in the treatment of breast cancer. Int J Nanomedicine. 2009;4:99-105.
Bao Y, Wen T, Samia AC, Khandhar A, Krishnan KM. Magnetic nanoparticles: material engineering and emerging applications in lithography and biomedicine. J Mater Sci. 2016;51(1):513-553.
Sowa P, Rutkowska-Talipska J, Rutkowski K, Kosztyła-Hojna B. Optical radiation in modern medicine. Postepy Dermatol Alergol. 2013;30(4):246-251.
Hirsh LR, Stafford RJ, Bankson JA, et al. Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc Natl Acad Sci USA. 2003;100(23):13549-13554.
Bozzuto G, Molinari A. Liposomes as nanomedical devices. Int J Nanomedicine. 2015;10:975-999.
Akbarzadeh A, Rezaei-Sadabady R, Davaran S, et al. Liposome: classification, preparation, and applications. Nanoscale Res Lett. 2013;8(1):102.
Bulbake U, Doppalapudi S, Kommineni N, Khan W. Liposomal formulations in clinical use: an updated review. Pharmaceutics. 2017;9(2):12.
Petre CE, Dittmer DP. Liposomal daunorubicin as treatment for Kaposi’s sarcoma. Int J Nanomedicine. 2007;2(3):277-288.
Luk BT, Fang RH, Zhang L. Lipid- and Polymer-Based Nanostructures for Cancer Theranostics. Theranostics 2012;2(12):1117-1126.
Rzeszutek J, Matysiak M, Czajka M, et al. Application of nanoparticles and nanomaterials in medicine. Hygeia Public Health 2014;49(3):449-457.
Douloudi M, Nikoli E, Katsika T, Vardavoulias M, Arkas M. Dendric polymers as promising additives for the manufacturing of hybrid organoceramic nanocomposites with ameliorated properties suitable for an extensive diversity of applications. Nanomaterials (Basel) 2020;11(1):19.
Luong JH, Male KB, Mahmoud KA, Sheu FS. Purification, functionalization, and bioconjugation of carbon nanotubes. Methods Mol Biol. 2011;751:505-532.
Zhao CY, Cheng R, Yang Z, Tian ZM. Nanotechnology for cancer therapy based on chemotherapy. Molecules 2018;23(4):826.
Barroso MM. Quantum dots in cell biology. J Histochem Cytochem. 2011;59(3):237-251.
Sapsford KE, Pons T, Medintz IL, Mattoussi H. Biosensing with lumines¬cent semiconductor quantum dots. Sensors 2006;6:925-953.
Jamieson T, Bakhshi R, Petrova D, Pocock R, Imani M, Seifalian AM. Bio¬logical applications of quantum dots. Biomaterials 2007;28:4717-4732.
Gao XH, Yezhelyev MV, Qi L, O'Regan RM, Nie SM. Proton-sponge-coated quantum dots for siRNA delivery and imaging. J Am Chem Soc. 2008:130;9006-9012.
Patra JK, Das G, Fraceto LF, et al. Nano based drug delivery systems: recent developments and future prospects. J Nanobiotechnology 2018;16(1):71.
Fang M, Peng CW, Pang DW, Li Y. Quantum dots for cancer research: current status, remaining issues, and future perspectives. Cancer Biol Med. 2012;9(3):151-163.
Murar M, Albertazzi L, Pujals S. Advanced optical imaging-guided nanotheranostics towards personalized cancer drug delivery. Nanomaterials 2022;12(3):399.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 European Journal of Clinical and Experimental Medicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition: this means that articles have free availability on the public Internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from having access to the Internet itself.
All articles are published with free open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0). If you submit your paper for publication by the Eur J Clin Exp Med, you agree to have the CC-BY license applied to your work. Under this Open Access license, you, as the author, agree that anyone may download and read the paper for free. In addition, the article may be reused and quoted provided that the original published version is cited. This facilitates freedom in re-use and also ensures that Eur J Clin Exp Med content can be mined without barriers for the research needs.
